Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
IL36G - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TBC1D30 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC730102 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CNTN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FMN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NBPF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLU7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LGR5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TATDN3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR51E2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COA7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAS2R45 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOPNL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRMT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC284561 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CELA3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EVI5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPAG5-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on